As the body ages, even familiar medicines become strangers — metabolized more slowly, complicated by other conditions, and capable of causing harm where they once brought relief. A research team at Boston University has mapped the landscape of spine pain medications for older adults, offering clinicians a hierarchy of options that honors both the need for relief and the vulnerabilities of aging. Their work is a reminder that effective medicine is not simply about what works, but for whom, at what dose, and at what cost to the rest of the body.
News-Medical.net
· Jun 29, 2022
· health
· 2 min de leitura
High
Apuração: Verificado
Study maps safe medication options for spine pain in older adults
◉
Health & Medicine
8525 artigos relacionados
FDA Approves Pancreatic Cancer Drug That May Extend Patient Survival
CBS News · 100% correspondência
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
ScienceAlert · 99% correspondência
Eli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
TODAY · 99% correspondência
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight-Loss Treatment
Interesting Engineering · 99% correspondência
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 99% correspondência
Cobertura Relacionada
BBC News · Aug 27
Facebook horse seller ordered to pay damages after selling unfit animals to buyers
Five women report being mis-sold unsafe or injured horses by a Facebook seller, with one buyer's daughter suffering a se…
Al Jazeera · Aug 27 Pakistan hospital fire kills 14 infants; families demand accountabilityFourteen babies died in a fire at Islamabad's Institute of Medical Sciences. Grieving families accuse hospital staff and…
Peter Attia MD · Aug 27 GLP-1 drugs show promise beyond metabolism, but questions remain about whyGLP-1 medications, originally developed for type 2 diabetes, now show potential benefits across metabolic and non-metabo…
Korea JoongAng Daily · Aug 27 Korean researchers identify Erbb4 protein as potential Alzheimer's breakthroughKorean researchers identified the Erbb4 protein as a key driver of Alzheimer's progression, showing it triggers synapse …
Viés e Enquadramento
⚖
Medical research article presenting evidence-based medication recommendations for spine pain in older adults with balanced assessment of safety and efficacy across drug classes.
Bias Direction
center
Confidence
HIGH
Evidence-based medical review framing that presents findings objectively across multiple medication classes with explicit safety considerations and clinical caveats.
Patient experiences and quality-of-life outcomes beyond pain management
Cost and accessibility considerations for older adults
Non-pharmacological treatment options (physical therapy, exercise, interventional procedures)
Perspectives from geriatric patients themselves on medication preferences
Comparative effectiveness data or head-to-head trial results
Impacto Geopolítico
🌎
Medical research on geriatric pain management has no geopolitical implications; this is a domestic healthcare policy matter.
Escalation Risk
N/A
Confidence
HIGH
Lente Econômica
📈
Research identifies acetaminophen as safe for elderly spine pain but NSAIDs more effective short-term; opioids limited due to risks, affecting pharmaceutical demand and healthcare costs.
Market Signal
mixed
Confidence
MED
Pharmaceutical manufacturing
Healthcare services
Geriatric care
Medical devices
Insurance/healthcare payers
Older adults gain clearer medication guidance reducing adverse effects and healthcare costs; potential shift from opioids to safer alternatives may improve quality of life but could increase out-of-pocket costs if preferred medications aren't covered.
Likely to influence Medicare/Medicaid formularies, encourage deprescribing of opioids in elderly populations, potentially increase regulatory scrutiny of NSAID use, and drive clinical practice guidelines adoption in geriatric pain management.